Table 6 Comparison of general information and gene expressions between patients with and without hematoma enlargement

Gender[cases (%)]

 Male

3(60.00)

13(65.00)

0.043

0.835

 Female

2(40.00)

7(35.00)

Age (\(\overline{x} \pm {\text{s}}\), years old)

67.20 ± 3.56

70.60 ± 4.60

1.531

0.139

Smoking history[cases (%)]

 Yes

3(60.00)

11(55.00)

0.041

0.840

 No

2(40.00)

9(45.00)

Systolic pressures (\(\overline{x} \pm {\text{s}}\), mmHg)

180.20 ± 6.06

176.45 ± 12.01

0.669

0.510

Diastolic pressures (\(\overline{x} \pm {\text{s}}\), mmHg)

105.40 ± 19.46

98.15 ± 11.04

1.123

0.273

Diabetes[cases (%)]

2(40.00)

11(55.00)

0.361

0.548

Hyperlipidemia[cases (%)]

2(40.00)

9(45.00)

0.041

0.840

Coronary heart disease[cases (%)]

0(0.00)

3(15.00)

0.852

0.356

Hypertension course (\(\overline{x} \pm {\text{s}}\), years)

11.20 ± 2.17

12.05 ± 3.27

0.547

0.586

Cerebral hemorrhage volume (\(\overline{x} \pm {\text{s}}\), ml)

56.40 ± 14.99

45.80 ± 9.44

1.997

0.058

Gene expressions

 SPI1

0.51 ± 0.01

0.67 ± 0.08

4.241

 < 0.001

 HK3

1.54 ± 0.19

1.46 ± 0.27

0.649

0.523

 HCK

1.52 ± 0.23

1.45 ± 0.18

0.795

0.435

 SYK

1.53 ± 0.20

1.47 ± 0.17

0.685

0.500

 CD14

1.52 ± 0.20

1.46 ± 0.18

0.628

0.536

 FCER1G

1.74 ± 0.17

1.65 ± 0.17

1.007

0.325

 CYBB

1.51 ± 0.22

1.41 ± 0.20

1.001

0.327

 FGR

1.61 ± 0.25

1.54 ± 0.18

0.786

0.440